financetom
Business
financetom
/
Business
/
What's Going On With Rigetti Computing Stock Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Rigetti Computing Stock Today?
Apr 1, 2025 7:17 AM

Rigetti Computing, Inc. ( RGTI ) saw its shares trade lower on Tuesday amid the announcement of a new exchange-traded fund launched by Defiance ETFs.

The ETF, called RGTX, is a 2X leveraged single-stock ETF designed to amplify exposure to Rigetti Computing ( RGTI ).

This new product allows traders to seek returns from Rigetti’s performance without the need for a margin account.

According to Benzinga Pro, RGTI stock has gained over 434% in the past year.

RGTX seeks daily investment results that correspond to twice (200%) the daily percentage change in Rigetti’s stock price.

Also Read: What’s Going On With IonQ Stock Today?

As a prominent player in the quantum computing industry, Rigetti has made significant strides in developing quantum processors and expanding its Quantum Computing as a Service (QCaaS) platform.

Sylvia Jablonski, CEO of Defiance ETFs, stated that the ETF provides a trading tool for those looking to capitalize on Rigetti’s market performance, particularly as the company continues to push forward with innovative research and technology.

Rigetti’s recent financial report for the fourth quarter showed revenue of $2.3 million, slightly missing analysts’ expectations of $2.5 million. The company reported an adjusted loss of eight cents per share, aligning with estimates.

Rigetti’s strategic agreement with Quanta Computer, a Taiwan-based leader in server manufacturing, signals promising growth ahead.

Both companies will invest over $100 million over the next five years, strengthening Rigetti’s position in the growing quantum computing market.

Investors can gain exposure to the stock via other ETFs like Invesco Dorsey Wright Technology Momentum ETF ( PTF ) and Spear Alpha ETF ( SPRX ) .

Price Action: RGTI shares are trading lower by 1.74% to $7.782 at last check Tuesday.

Read Next:

China’s XPeng Clocks Record Q1 EV Sales, Deliveries Surge 3.6X

Image via Shutterstock.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Daura Gold Rises After Upsizing Private Placement to $6.5 Million
Daura Gold Rises After Upsizing Private Placement to $6.5 Million
Sep 25, 2025
02:11 PM EDT, 09/25/2025 (MT Newswires) -- Daura Gold ( DGCOF ) shares rose 9.7% at last look on Thursday after it upsized a non-brokered private placement of share units to $6.5 million from $5 million. The company will offer up to 26-million units priced at $0.25 each and made up of a share and one half of a two-year...
General Dynamics secures $1.5 billion IT contract for STRATCOM
General Dynamics secures $1.5 billion IT contract for STRATCOM
Sep 25, 2025
Sept 25 (Reuters) - General Dynamics ( GD ) said on Thursday its information technology unit has secured an enterprise modernization contract worth $1.5 billion, to help support the U.S. Strategic Command, or STRATCOM. The new contract, awarded to General Dynamics ( GD ) in May, covers a one-year base period and six option years. Under the contract, General Dynamics...
US NIH's $50 million autism initiative grounded in science
US NIH's $50 million autism initiative grounded in science
Sep 25, 2025
* US NIH funds 13 autism research projects with $50 million * Focus on genetic, environmental, clinical, and behavioral data * Projects contrast with other government autism efforts By Ahmed Aboulenein and Robin Respaut WASHINGTON, Sept 25 (Reuters) - The U.S. National Institutes of Health granted $50 million this week to fund 13 autism research projects that scientists and advocates...
US FDA approves Eli Lilly's therapy for metastatic breast cancer
US FDA approves Eli Lilly's therapy for metastatic breast cancer
Sep 25, 2025
Sept 25 (Reuters) - Eli Lilly ( LLY ) said on Thursday that the U.S. Food and Drug Administration has approved its therapy for the treatment of metastatic breast cancer in patients whose disease progressed after at least one line of endocrine therapy. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved